As
filed with the Securities and Exchange Commission on May 1,
2009
|
Registration
No. 333-152660
|
Delaware
|
2834
|
52-2286452
|
(State
or other jurisdiction of incorporation or organization)
|
(Primary
Standard Industrial Classification Code Number)
|
(I.R.S.
Employer
Identification
No.)
|
Brian
Lenz
Chief
Financial Officer
Arno
Therapeutics, Inc.
4
Campus Drive, 2nd
Floor
Parsippany,
New Jersey, 07054
(862)
703-7175
(Name, address,
including zip code, and telephone number,
including
area code, of agent for service)
|
Copies
to:
Christopher
J. Melsha, Esq.
Fredrikson
& Byron, P.A.
200
South Sixth Street, Suite 4000
Minneapolis,
MN 55402-1425
Telephone:
(612) 492-7000
Facsimile:
(612) 492-7077
|
Large
accelerated filer o
|
Accelerated
filer o
|
|
Non-accelerated
filer o (Do not check if
a smaller reporting company)
|
Smaller
reporting company þ
|
ARNO THERAPEUTICS, INC. | |||
|
By:
|
/s/ Brian Lenz | |
Brian
Lenz
Chief
Financial Officer
|
|||
Signature
|
Title
|
Date
|
|||
/s/
Roger G. Berlin
|
Chief
Executive Officer and Director
|
May
1, 2009
|
|||
Roger
G. Berlin, M.D.
|
(Principal
Executive Officer)
|
||||
/s/
Brian Lenz
|
Chief
Financial Officer
|
May
1, 2009
|
|||
Brian
Lenz
|
(Principal
Financial and Accounting Officer)
|
||||
*
|
Non-Executive
Chairman and Director
|
May
1, 2009
|
|||
Arie
S. Belldegrun, M.D.
|
|||||
*
|
Director
|
May
1, 2009
|
|||
Robert
I. Falk
|
|||||
Director
|
May
__, 2009
|
||||
William
F. Hamilton, Ph.D.
|
|||||
*
|
Director
|
May
1, 2009
|
|||
Peter
M. Kash
|
|||||
*
|
Director
|
May
1, 2009
|
|||
Joshua
A. Kazam
|
|||||
/s/
David M. Tanen
|
Director
|
May
1, 2009
|
|||
David
M. Tanen
|
|||||
*
|
/s/
David M. Tanen
|
||||
David
M. Tanen
Attorney-in-fact
|